Despite the recent decrease in overall prevalence of Helicobacter pylori infection, morbidity
and mortality rates associated with gastric cancer remain high. The antimicrobial resistance …

Helicobacter pylori (H. pylori) infection is highly prevalent in the human population and may
lead to severe gastrointestinal pathology including gastric and duodenal ulcers, mucosa …

Metronidazole and clarithromycin resistance rates are alarming although they vary among
populations. Tetracycline and amoxicillin-resistance are very low in most countries. H. pylori …

Despite the declining trend of Helicobacter pylori (H. pylori) prevalence around the globe,
ongoing efforts are still needed to optimize current and future regimens in view of the …

Abstract Background Shanghai, in east China, has one of the world's highest burdens of
Helicobacter pylori infection. While multidrug regimens can effectively eradicate H. pylori …

The Gram-negative bacterium Helicobacter pylori colonizes ca 50% of human stomachs
worldwide and is the major risk factor for gastric adenocarcinoma. Its high genetic variability …

Helicobacter pylori is a gastric pathogen that infects nearly half of the global population and
is recognized as a group 1 carcinogen by the Word Health Organization. The global rise in …

Background Knowledge of global clarithromycin (CLA)-resistant rates of Helicobacter pylori
(H. pylori) is crucial for decision of the most appropriate eradication therapies with good …

Helicobacter pylori drug resistance presents a significant challenge to the successful
eradication of this pathogen. To find strategies to improve the eradication efficacy of H …

The high prevalence of antibiotic resistance in Helicobacter pylori has become a great
challenge in Iran. The genetic mutations that contribute to the resistance have yet to be …